• Thurs news: GSK inks 2nd neuro pact in weeks. Teva episodic migraine trial. FDA clears AZ’s Imfinzi for aggressive lung cancer. Novartis fails to block generic Entresto. Nuvig gets immune drug funding. See more on our front page

Q4 Goals

























Stay far away from here all HO leadership is amateur talent it’s really scary how many people have left or are leaving. Everyone is looking

Amen to that we have a bunch of leaders here who have no idea what they are doing and talk about arrogance OMG they are so high on themselves its a joke. Another Friday with conference calls about nothing. OP is right stay away